• Explore /
  • Poster
  • / Characterizing tumor responses from RAINBOW, a randomized phase III trial of ramucirumab (RAM) plus paclitaxel (PAC) vs placebo (PBO) plus PAC in patients (pts) with previously treated advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Characterizing tumor responses from RAINBOW, a randomized phase III trial of ramucirumab (RAM) plus paclitaxel (PAC) vs placebo (PBO) plus PAC in patients (pts) with previously treated advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Abstract Poster

Authors

null

Gyorgy Bodoky

Szent László Hospital, Budapest, Hungary

Gyorgy Bodoky , Marian Gil-Delgado , Stefano Cascinu , Oleg N. Lipatov , David Cunningham , Eric Van Cutsem , Kei Muro , Kumari Chandrawansa , Astra M. Liepa , Roberto Carlesi , Atsushi Ohtsu , Hansjochen Wilke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01170663

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 45)

DOI

10.1200/jco.2016.34.4_suppl.45

Abstract #

45

Poster Bd #

H1

Abstract Disclosures

Similar Posters

First Author: Salah-Eddin Al-Batran

First Author: John H. Strickler

First Author: Daniel V.T. Catenacci

First Author: Richard S. Finn